Cargando…
Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients
BACKGROUND: Bone marrow stromal antigen 2 (BST-2) also known as Tetherin (CD317/HM1.24), is a host restriction factor that blocks the release of HIV-1 virions from infected cells. Previous studies reported that BST-2 genetic variants or single nucleotide polymorphims (SNPs) have a preventative role...
Autores principales: | Mlimi, Hlelolwenkosi, Naidoo, Kewreshini K., Mabuka, Jenniffer, Ndung’u, Thumbi, Madlala, Paradise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793201/ https://www.ncbi.nlm.nih.gov/pubmed/35081977 http://dx.doi.org/10.1186/s12977-022-00588-2 |
Ejemplares similares
-
Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection
por: Naidoo, Kewreshini K., et al.
Publicado: (2021) -
Neutrophil Effector Functions Are Not Impaired in Duffy Antigen Receptor for Chemokines (DARC)-Null Black South Africans
por: Naidoo, Kewreshini K., et al.
Publicado: (2019) -
Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles
por: Moyano, Ana, et al.
Publicado: (2023) -
Bone Marrow Stromal Antigen 2 (BST-2) DNA Is Demethylated in Breast Tumors and Breast Cancer Cells
por: Mahauad-Fernandez, Wadie D., et al.
Publicado: (2015) -
Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis
por: Singh, Ravesh, et al.
Publicado: (2021)